-+ 0.00%
-+ 0.00%
-+ 0.00%

TD Cowen Downgrades Foghorn Therapeutics to Hold

Benzinga·10/02/2026 14:25:02
TD Cowen analyst Yaron Werber downgrades Foghorn Therapeutics (NASDAQ:FHTX) from Buy to Hold.